MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma

Por Peng, Xiao Hong, Huang, Hao Ran, Lu, Juan, Liu, Xiong, Zhao, Fei Peng, Zhang, Bao, Lin, Shao Xiong, Wang, Lu, Chen, Huai Hong, Xu, Xia, Wang, Fan, Li, Xiang Ping
Publicado no Mol Cancer (2014)

Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma

Por ZHAO, FEI-PENG, LIU, XIONG, CHEN, XIAO-MEI, LU, JUAN, YU, BO-LONG, TIAN, WEN-DONG, WANG, LU, XU, XIA, HUANG, HAO-RAN, ZHANG, MENG-WEN, LI, GANG, LI, XIANG-PING
Publicado no Oncol Lett (2015)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma

Por Zhao, Fei-Peng, Liu, Xiong, Zhong, Zhi-Ming, Lu, Juan, Yu, Bo-Long, Zeng, Fang-Yin, Chen, Xiao-Mei, Chen, Huai-Hong, Peng, Xiao-Hong, Wang, Fan, Peng, Ying, Li, Xiang-Ping
Publicado no BBA Clin (2014)

EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma

Por Lu, Juan, Zhao, Fei-Peng, Peng, Zengliu, Zhang, Meng-Wen, Lin, Shao-Xiong, Liang, Bi-Jun, Zhang, Bao, Liu, Xiong, Wang, Lu, Li, Gang, Tian, Wen-Dong, Peng, Ying, He, Ming-Liang, Li, Xiang-Ping
Publicado no Oncotarget (2014)